Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Selekad
- Development stage
- Unknown
- Lead developer
- Grand Medical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Selekad is a gastroenterology health supplement developed by Grand Medical Group. Formulated as oral capsules, it contains a combination of Silybum marianum (milk thistle) fruit extract (standardized to silymarin) and selenium. Selekad is utilized as a hepatoprotective agent to support liver function, protect hepatocytes from oxidative stress and toxic damage (such as from alcohol, heavy metals, or medications), and assist in the recovery from chronic inflammatory liver diseases, cirrhosis, and hepatitis.
- Brand names
- Selekad
- Other names
- Silybum marianum fruit extract + seleniumsilymarin + selenium
Beyond the preview
Go deeper on Selekad.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Selekad.